Parexel is a pharmaceutical company focusing on clinical research, medical communications, consulting, commercialization, and advanced technology products and services. Founded in 1983 and headquartered in Waltham, Massachusetts, Parexel serves the pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). With a diverse workforce of 18,900 employees, Parexel has an annual revenue of $2.4 billion.
Under the leadership of CEO Jamie MacDonald, Parexel offers a wide selection of services including clinical trials management, observational studies, patient/disease registries, post-marketing surveillance, data management, biostatistics, epidemiology, health economics/outcomes research, clinical logistics, pharmacovigilance, and clinical pharmacology. The company also provides technical expertise in drug development, regulatory affairs, product pricing and reimbursement, and good manufacturing practice compliance consulting. In addition to its core services, Parexel's Perceptive segment offers information technology solutions like medical imaging systems integration services and web-based portals for clients.
